News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 22, 2017

Active Surveillance in Prostate Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

A real-world study found Erleada reduced the risk of death compared with darolutamide in patients with metastatic castration-sensitive prostate cancer: © stock.adobe.com.

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

February 2nd 2026

Brian Sluga is now a testicular cancer survivor after receiving the diagnosis when he was 20 years old. Catch up on Brian's blogs here!

Finding My Power of One After Cancer

January 19th 2026

Ronald Wakefield and Ernie Strauss

Advice From Two Prostate Cancer Survivors For Newly Diagnosed Patients

January 14th 2026

prostate cancer

FDA Fast Tracks Enolen For Localized Prostate Cancer Treatment

January 11th 2026

Ernie Strauss and Ronald Wakefield

Facing Misconceptions and Stigmas of Prostate Cancer Together

ByRonald Wakefield,Ernie Strauss

January 6th 2026

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

KTX-1001 Elicits Responses in Some With Multiple Myeloma

Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma

New Combination Treatment Approach Studied in Pancreatic Cancer